The main pathways are closely related to the pathways in cancer, prostate cancer, PI3K-Akt signaling pathway, EGFR tyrosine kinase inhibitor resistance, endocrine resistance, etc (Fig. 5D). This evidence concerns the gene AKT1 and prostate cancer.